Mirvie RNA platform first to uncover unique molecular signal for babies at risk of severe fetal growth restriction

Research presented at Society for Maternal-Fetal Medicine annual meeting demonstrates Mirvie’s breakthrough technology can predict babies with severe growth restriction, a leading cause of stillbirth

Mirvie